Description
Baidyanath Trayodashang Guggulu Tablet is a Guggulu based ayurvedic formulation that is effective for conditions related to the nervous and musculoskeletal system. It helps strengthen the joints, bones, ligaments and reduces the pain.
Baidyanath Trayodashang Guggulu
Related products
Himalaya Clarina Anti Acne Face Wash Gel
₹14.00Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
Sale!
₹440.00 ₹418.00
Kottakkal Rasasinduram Capsule
kottakkal Rasasinduram Dosage: 4 capsule once or twice daily or as directed by the Physician Usage:1 capsule once or twice daily followed by suitable anupana according to the condition Indications: Chronic and recurrent infection, Benign and Malignant neoplasms.
Sale!
₹900.00 ₹850.00
Pravek Nervokalp
Effective in neuromuscular disorder, memory retention, loss of consciousness, insanity, hysteria, spondylitis, ligament and tendon weakness, general debility, etc.
Helpful in neurological disorders like epilepsy, mental weakness, Parkinson’s disease, neuropathies, hemiplegia, paralysis, paraplegia, nervous breakdown, etc.
Helpful in muscular disorders, blood disorders, cancer and other chronic diseases, etc.
DESCRIPTION SUGGESTED DOSAGE INGREDIENTS NUTRITIONAL INFORMATION PRECAUTIONS PACKAGING INFO
Sale!
Sale!
₹505.00 ₹424.00
Aimil BGR 34 Tablets
Aimil BGR 34, BGR 34 DESCRIPTION-BGR 34 ONLINE IN INDIA – GOVT APPROVED ANTI DIABETIC TABLET WHAT IS BGR-34? BGR-34, a Blood Glucose Regulator brings the revolution, with a breakthrough Phyto-research of decade, jointly developed by scientist of CSIR-NBRI & CSIR- CIMAP. BGR-34 manages the lives of suffering Diabetics. It is an optimized concentration of synergistically acting herbal extracts makes…
Dr JRK Siddha Dano Anti Dandruff Oil
₹99.00There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don’t look even slightly believable.
Reviews
There are no reviews yet.